ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
126.692,13
-0,56%
S&P 500
5.317,32
-0,08%
US Dollar vs BRL
5,1493
0,51%
Bitcoin
69.807,86
-0,46%
Brent Oil
81,675
-0,93%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Charles River Laboratories International Inc (CRL)

  7. Charles River Laboratories International Inc (CRL) Notícias

CRL

Charles River Laboratories (CRL)

Charles River Laboratories International Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:CRL
DataHoraFonteTítuloCódigoCompanhia
16/05/202417:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
15/05/202417:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:CRLCharles River Laboratories International Inc
10/05/202417:07Edgar (US Regulatory)Form 8-K - Current reportNYSE:CRLCharles River Laboratories International Inc
09/05/202417:20Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:CRLCharles River Laboratories International Inc
09/05/202410:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:CRLCharles River Laboratories International Inc
09/05/202408:00Business WireCharles River Laboratories Announces First-Quarter 2024 ResultsNYSE:CRLCharles River Laboratories International Inc
02/05/202409:00Business WireCharles River Launches Viral Vector Reference Materials to Streamline the Transition to GMPNYSE:CRLCharles River Laboratories International Inc
22/04/202409:00Business WireCharles River Laboratories Achieves 100% Renewable Electricity Usage GloballyNYSE:CRLCharles River Laboratories International Inc
16/04/202409:00Business WireCharles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal TestingNYSE:CRLCharles River Laboratories International Inc
12/04/202409:00Business WireCharles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference CallNYSE:CRLCharles River Laboratories International Inc
11/04/202409:00Business WireCharles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic PathologyNYSE:CRLCharles River Laboratories International Inc
09/04/202409:00Business WireCharles River Announces Rare Disease Gene Therapy Collaboration with Axovia TherapeuticsNYSE:CRLCharles River Laboratories International Inc
04/04/202409:00Business WireCharles River to Perform Plasmid Production for Ship of TheseusNYSE:CRLCharles River Laboratories International Inc
01/04/202409:00Business WireCharles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024NYSE:CRLCharles River Laboratories International Inc
27/03/202409:00Business WireCharles River Laboratories Publishes 2023 Corporate Citizenship ReportNYSE:CRLCharles River Laboratories International Inc
21/03/202409:00Business WireCharles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of MedicineNYSE:CRLCharles River Laboratories International Inc
14/03/202409:00Business WireCharles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing CollaborationNYSE:CRLCharles River Laboratories International Inc
12/03/202409:00Business WireCharles River Laboratories to Present at Barclays Global Healthcare ConferenceNYSE:CRLCharles River Laboratories International Inc
29/02/202404:00PR Newswire (US)Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-in-Human UseNYSE:CRLCharles River Laboratories International Inc
21/02/202410:00Business WireCharles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to ManufacturingNYSE:CRLCharles River Laboratories International Inc
20/02/202410:08Business WireCharles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem CellsNYSE:CRLCharles River Laboratories International Inc
14/02/202409:00Business WireCharles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 GuidanceNYSE:CRLCharles River Laboratories International Inc
31/01/202419:34Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:CRLCharles River Laboratories International Inc
30/01/202418:43Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
29/01/202410:00Business WireCharles River Introduces the First Rapid Animal-Free Bacterial Endotoxin TestNYSE:CRLCharles River Laboratories International Inc
24/01/202418:30Business WireCharles River Laboratories Adds Reshema Kemps-Polanco to Board of DirectorsNYSE:CRLCharles River Laboratories International Inc
23/01/202418:30Business WireCharles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference CallNYSE:CRLCharles River Laboratories International Inc
16/01/202410:00Business WireCharles River Launches Rep/Cap Plasmids to Streamline Adeno-Associated Viral Vector ManufacturingNYSE:CRLCharles River Laboratories International Inc
08/01/202410:00Business WireCharles River Laboratories to Present at J.P. Morgan Healthcare ConferenceNYSE:CRLCharles River Laboratories International Inc
18/12/202310:00Business WireCharles River and Vertex Pharmaceuticals Reach Important Milestone in Cell Therapy Manufacturing CollaborationNYSE:CRLCharles River Laboratories International Inc
 Apresentando as notícias mais relevantes sobre:NYSE:CRL

Seu Histórico Recente

USOTC
ONSS
Onassis (PK)
NASDAQ
SPI
SPI Energy
COIN
DBBETH
Dragon Blood
LSE
RGO
Riverfort Global Opportu...
LSE
TWTS
Ls -1x Twitter
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados